NVO EPS Estimates
Novo Nordisk A/S
$39.47
+$1.35(+3.53%)
47
Overall
85
Value
18
Tech
39
Quality
Market Cap
$168.79B
Volume
7.85M
52W Range
$35.12 - $64.16
Target Price
$46.38
NVO EPS estimates: the consensus estimate for Novo Nordisk A/S's current fiscal year is $3.53 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
NVO EPS Estimates
- EPS estimate, current quarter
- $0.80
- EPS estimate, next quarter
- $0.77
- EPS estimate, current year
- $3.53
- EPS estimate, next year
- $3.41
- EPS growth, 3-year
- +0.00%
| Fiscal year | EPS |
|---|---|
| 2024 | $22.67 |
| 2023 | $18.67 |
| 2022 | $12.26 |
| 2021 | $10.40 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NVO | $39.47 | +3.5% | 7.85M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |